-
nct03181490: multi-centers validation of a circulating tumor dna assay to differentiate benign and malignant pulmonary nodules via targeted high-throughput dna methylation sequencing
this is a prospective-specimen collection, retrospective-blinded-evaluation (probe) clinical study co-led by anchordx medical co. ltd and the first affiliated hospital of guangzhou medical university with 14 clinical centers participating
know more -
thunder projec (nct03651986): diagnostic and monitoring significance of circulating tumor dna (ctdna) methylation analysis by next-generation sequencing in benign and malignant pulmonary nodules
the “thunder project” is a prospective observational study led by academician nanshan zhong and anchordx in collaboration with 23 clinical centers. the study aims to recruit 10,560 participants with 5-30 mm pulmonary nodules. all participants will be foll
know more -
angel program (nct04462185): a prospective cohort study of chinese patients with pulmonary nodules: prediction of lung cancer using noninvasive biomarkers
the angel program is a prospective observational study led by academician nanshan zhong, anchordx and johnson & johnson lung cancer initiative (lci) with six clinical centers participating. the study aims to recruit 3,000 patients with indeterminate p
know more -
nct04314245: diagnostic evaluation of urine dna methylation/somatic mutation profiling for the detection of urothelial carcinoma
the bc004 program was led by prof. jiang huang, the director of society of urology of chinese medical association and the director of the department of urinary surgery, sun yat-sen memorial hospital, sun yat-sen university and anchordx
know more